Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22, Canaccord raised the firm’s price target on Guardant Health to $125 from$100 with a Buy rating on the shares. The firm expects the life science sector to maintain its current upward trend well into 2026. Guardant Health remains Canaccord’s top recommendation, as the firm believes that the stock offers the best balance of limited downside and strong growth potential compared to its peers. Mizuho also raised t ...